These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11983186)

  • 1. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome.
    Rausch JL; Johnson ME; Fei YJ; Li JQ; Shendarkar N; Hobby HM; Ganapathy V; Leibach FH
    Biol Psychiatry; 2002 May; 51(9):723-32. PubMed ID: 11983186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter gene polymorphism and antidepressant response.
    Kim DK; Lim SW; Lee S; Sohn SE; Kim S; Hahn CG; Carroll BJ
    Neuroreport; 2000 Jan; 11(1):215-9. PubMed ID: 10683861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.
    Pollock BG; Ferrell RE; Mulsant BH; Mazumdar S; Miller M; Sweet RA; Davis S; Kirshner MA; Houck PR; Stack JA; Reynolds CF; Kupfer DJ
    Neuropsychopharmacology; 2000 Nov; 23(5):587-90. PubMed ID: 11027924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
    Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M
    Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
    Yoshida K; Takahashi H; Higuchi H; Kamata M; Ito K; Sato K; Naito S; Shimizu T; Itoh K; Inoue K; Suzuki T; Nemeroff CB
    Am J Psychiatry; 2004 Sep; 161(9):1575-80. PubMed ID: 15337646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.
    Yu YW; Tsai SJ; Chen TJ; Lin CH; Hong CJ
    Mol Psychiatry; 2002; 7(10):1115-9. PubMed ID: 12476327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder.
    Silva H; Iturra P; Solari A; Villarroel J; Jerez S; Jiménez M; Galleguillos F; Bustamante ML
    Psychiatr Genet; 2010 Feb; 20(1):25-30. PubMed ID: 20010449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
    Weizman A; Weizman R
    Pharmacogenomics; 2000 Aug; 1(3):335-41. PubMed ID: 11256582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
    Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
    Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.
    Mann JJ; Huang YY; Underwood MD; Kassir SA; Oppenheim S; Kelly TM; Dwork AJ; Arango V
    Arch Gen Psychiatry; 2000 Aug; 57(8):729-38. PubMed ID: 10920459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis.
    Rausch JL; Hobby HM; Shendarkar N; Johnson ME; Li J
    J Clin Psychopharmacol; 2001 Apr; 21(2):139-42. PubMed ID: 11270909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.
    Durham LK; Webb SM; Milos PM; Clary CM; Seymour AB
    Psychopharmacology (Berl); 2004 Aug; 174(4):525-9. PubMed ID: 12955294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
    Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
    Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
    Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
    Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
    Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH
    Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
    Zanardi R; Serretti A; Rossini D; Franchini L; Cusin C; Lattuada E; Dotoli D; Smeraldi E
    Biol Psychiatry; 2001 Sep; 50(5):323-30. PubMed ID: 11543734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.